Open AccessEfficacy and Safety of Low-Dose Rituximab in Anti-MuSK Myasthenia Gravis Patients: A Retrospective Study
Author(s) -
Xin Meng,
Ziling Zeng,
Yunda Wang,
Shaoyun Guo,
Chunjuan Wang,
Baojie Wang,
Shougang Guo
Publication year - 2022
Publication title -
neuropsychiatric disease and treatment
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.819
H-Index - 67
eISSN - 1178-2021
pISSN - 1176-6328
DOI - 10.2147/ndt.s358851
Subject(s) - medicine , myasthenia gravis , rituximab , retrospective cohort study , lymphoma
To evaluate the efficacy and safety of low dosages of rituximab (RTX) in the treatment of MuSK-antibody-positive MG patients.